Additionally, several genetic alterations including MEG3 polymorphisms [36], ERCC1/XPF [37], and NRAS [38] were associated with the occurrence of neuroblastoma and might serve as important diagnosis biomarkers in the future [13]. This evidence concerns the gene MEG3 and neuroblastoma.